BGI-Shenzhen Announces Extension of Tender Offer For Complete Genomics

BGI-Shenzhen Announces Extension of Tender Offer For Complete Genomics
BGI-Shenzhen ("BGI") announced today that it, through its wholly owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: …
Read more on Benzinga

Leave a Reply